nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ORM1—Saquinavir—acquired immunodeficiency syndrome	0.0502	0.0679	CbGbCtD
Trazodone—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0299	0.0404	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0299	0.0404	CbGbCtD
Trazodone—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0258	0.0348	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0258	0.0348	CbGbCtD
Trazodone—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.025	0.0338	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.025	0.0338	CbGbCtD
Trazodone—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0248	0.0335	CbGbCtD
Trazodone—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0226	0.0306	CbGbCtD
Trazodone—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0226	0.0306	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0226	0.0306	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0226	0.0306	CbGbCtD
Trazodone—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0224	0.0303	CbGbCtD
Trazodone—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0224	0.0303	CbGbCtD
Trazodone—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0193	0.0261	CbGbCtD
Trazodone—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0188	0.0254	CbGbCtD
Trazodone—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.017	0.0229	CbGbCtD
Trazodone—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.017	0.0229	CbGbCtD
Trazodone—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0162	0.0218	CbGbCtD
Trazodone—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0161	0.0218	CbGbCtD
Trazodone—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0152	0.0205	CbGbCtD
Trazodone—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0152	0.0205	CbGbCtD
Trazodone—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0146	0.0197	CbGbCtD
Trazodone—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0137	0.0186	CbGbCtD
Trazodone—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0137	0.0186	CbGbCtD
Trazodone—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0126	0.017	CbGbCtD
Trazodone—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0122	0.0165	CbGbCtD
Trazodone—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0119	0.016	CbGbCtD
Trazodone—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0115	0.0156	CbGbCtD
Trazodone—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.011	0.0149	CbGbCtD
Trazodone—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.011	0.0149	CbGbCtD
Trazodone—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0106	0.0143	CbGbCtD
Trazodone—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0104	0.0141	CbGbCtD
Trazodone—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0104	0.0141	CbGbCtD
Trazodone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0103	0.0139	CbGbCtD
Trazodone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00966	0.0131	CbGbCtD
Trazodone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00966	0.0131	CbGbCtD
Trazodone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00873	0.0118	CbGbCtD
Trazodone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00873	0.0118	CbGbCtD
Trazodone—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00819	0.0111	CbGbCtD
Trazodone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00754	0.0102	CbGbCtD
Trazodone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00732	0.00989	CbGbCtD
Trazodone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00662	0.00895	CbGbCtD
Trazodone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00662	0.00895	CbGbCtD
Trazodone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00634	0.00858	CbGbCtD
Trazodone—ORM1—saliva—acquired immunodeficiency syndrome	0.00417	0.0947	CbGeAlD
Trazodone—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00155	0.0351	CbGeAlD
Trazodone—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00137	0.0312	CbGeAlD
Trazodone—HTR2A—nerve—acquired immunodeficiency syndrome	0.00108	0.0246	CbGeAlD
Trazodone—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.00101	0.0229	CbGeAlD
Trazodone—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000963	0.0219	CbGeAlD
Trazodone—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000922	0.0209	CbGeAlD
Trazodone—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000819	0.0186	CbGeAlD
Trazodone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000758	0.0172	CbGeAlD
Trazodone—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000746	0.0169	CbGeAlD
Trazodone—HTR2B—skin of body—acquired immunodeficiency syndrome	0.000737	0.0167	CbGeAlD
Trazodone—ORM1—blood—acquired immunodeficiency syndrome	0.000665	0.0151	CbGeAlD
Trazodone—ORM1—bone marrow—acquired immunodeficiency syndrome	0.000644	0.0146	CbGeAlD
Trazodone—ORM1—spinal cord—acquired immunodeficiency syndrome	0.000641	0.0145	CbGeAlD
Trazodone—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000595	0.0135	CbGeAlD
Trazodone—HTR2B—digestive system—acquired immunodeficiency syndrome	0.000589	0.0134	CbGeAlD
Trazodone—ORM1—lung—acquired immunodeficiency syndrome	0.000583	0.0132	CbGeAlD
Trazodone—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000576	0.0131	CbGeAlD
Trazodone—SLC6A4—blood—acquired immunodeficiency syndrome	0.000567	0.0129	CbGeAlD
Trazodone—HTR2B—blood—acquired immunodeficiency syndrome	0.000562	0.0127	CbGeAlD
Trazodone—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000546	0.0124	CbGeAlD
Trazodone—ORM1—nervous system—acquired immunodeficiency syndrome	0.00054	0.0123	CbGeAlD
Trazodone—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000536	0.0122	CbGeAlD
Trazodone—HTR2B—vagina—acquired immunodeficiency syndrome	0.000521	0.0118	CbGeAlD
Trazodone—ORM1—central nervous system—acquired immunodeficiency syndrome	0.00052	0.0118	CbGeAlD
Trazodone—SLC6A4—lung—acquired immunodeficiency syndrome	0.000497	0.0113	CbGeAlD
Trazodone—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000493	0.0112	CbGeAlD
Trazodone—HTR2B—lung—acquired immunodeficiency syndrome	0.000492	0.0112	CbGeAlD
Trazodone—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000485	0.011	CbGeAlD
Trazodone—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000485	0.011	CbGeAlD
Trazodone—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000467	0.0106	CbGeAlD
Trazodone—ADRA1A—blood—acquired immunodeficiency syndrome	0.000464	0.0105	CbGeAlD
Trazodone—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.00046	0.0104	CbGeAlD
Trazodone—HTR2B—nervous system—acquired immunodeficiency syndrome	0.000456	0.0103	CbGeAlD
Trazodone—HTR2A—retina—acquired immunodeficiency syndrome	0.000448	0.0102	CbGeAlD
Trazodone—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000443	0.0101	CbGeAlD
Trazodone—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.000439	0.00996	CbGeAlD
Trazodone—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000409	0.00927	CbGeAlD
Trazodone—ORM1—lymph node—acquired immunodeficiency syndrome	0.000399	0.00905	CbGeAlD
Trazodone—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000393	0.00893	CbGeAlD
Trazodone—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000388	0.00882	CbGeAlD
Trazodone—HRH1—digestive system—acquired immunodeficiency syndrome	0.000377	0.00856	CbGeAlD
Trazodone—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000377	0.00855	CbGeAlD
Trazodone—HTR2C—brain—acquired immunodeficiency syndrome	0.000371	0.00842	CbGeAlD
Trazodone—CYP3A5—blood—acquired immunodeficiency syndrome	0.00037	0.0084	CbGeAlD
Trazodone—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000363	0.00823	CbGeAlD
Trazodone—ADRA2A—blood—acquired immunodeficiency syndrome	0.000353	0.00801	CbGeAlD
Trazodone—SLC6A4—brain—acquired immunodeficiency syndrome	0.000352	0.00798	CbGeAlD
Trazodone—HTR2B—brain—acquired immunodeficiency syndrome	0.000348	0.00791	CbGeAlD
Trazodone—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000343	0.00778	CbGeAlD
Trazodone—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.00034	0.00771	CbGeAlD
Trazodone—HTR2B—lymph node—acquired immunodeficiency syndrome	0.000337	0.00764	CbGeAlD
Trazodone—HRH1—vagina—acquired immunodeficiency syndrome	0.000333	0.00756	CbGeAlD
Trazodone—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000327	0.00742	CbGeAlD
Trazodone—CYP3A5—lung—acquired immunodeficiency syndrome	0.000324	0.00736	CbGeAlD
Trazodone—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000315	0.00715	CbGeAlD
Trazodone—HRH1—lung—acquired immunodeficiency syndrome	0.000315	0.00715	CbGeAlD
Trazodone—HTR1A—brain—acquired immunodeficiency syndrome	0.000312	0.00709	CbGeAlD
Trazodone—ADRA2A—lung—acquired immunodeficiency syndrome	0.000309	0.00702	CbGeAlD
Trazodone—HTR2A—blood—acquired immunodeficiency syndrome	0.0003	0.00681	CbGeAlD
Trazodone—ABCB1—retina—acquired immunodeficiency syndrome	0.000294	0.00667	CbGeAlD
Trazodone—HRH1—nervous system—acquired immunodeficiency syndrome	0.000291	0.00662	CbGeAlD
Trazodone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000291	0.00662	CbGeAlD
Trazodone—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000289	0.00656	CbGeAlD
Trazodone—ADRA1A—brain—acquired immunodeficiency syndrome	0.000288	0.00653	CbGeAlD
Trazodone—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000287	0.00651	CbGeAlD
Trazodone—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000286	0.0065	CbGeAlD
Trazodone—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000281	0.00637	CbGeAlD
Trazodone—HTR2A—vagina—acquired immunodeficiency syndrome	0.000278	0.00631	CbGeAlD
Trazodone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000278	0.0063	CbGeAlD
Trazodone—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000276	0.00626	CbGeAlD
Trazodone—CYP2D6—blood—acquired immunodeficiency syndrome	0.000273	0.0062	CbGeAlD
Trazodone—HTR2A—lung—acquired immunodeficiency syndrome	0.000263	0.00597	CbGeAlD
Trazodone—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000243	0.00553	CbGeAlD
Trazodone—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000234	0.00532	CbGeAlD
Trazodone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000225	0.00512	CbGeAlD
Trazodone—HRH1—brain—acquired immunodeficiency syndrome	0.000223	0.00506	CbGeAlD
Trazodone—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000222	0.00503	CbGeAlD
Trazodone—ADRA2A—brain—acquired immunodeficiency syndrome	0.000219	0.00497	CbGeAlD
Trazodone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000217	0.00493	CbGeAlD
Trazodone—HRH1—lymph node—acquired immunodeficiency syndrome	0.000215	0.00489	CbGeAlD
Trazodone—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000214	0.00485	CbGeAlD
Trazodone—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000211	0.0048	CbGeAlD
Trazodone—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000209	0.00474	CbGeAlD
Trazodone—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000206	0.00468	CbGeAlD
Trazodone—ABCB1—blood—acquired immunodeficiency syndrome	0.000197	0.00446	CbGeAlD
Trazodone—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.00019	0.00432	CbGeAlD
Trazodone—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000189	0.0043	CbGeAlD
Trazodone—HTR2A—brain—acquired immunodeficiency syndrome	0.000186	0.00422	CbGeAlD
Trazodone—ABCB1—vagina—acquired immunodeficiency syndrome	0.000182	0.00414	CbGeAlD
Trazodone—ABCB1—lung—acquired immunodeficiency syndrome	0.000172	0.00391	CbGeAlD
Trazodone—CYP2D6—brain—acquired immunodeficiency syndrome	0.00017	0.00385	CbGeAlD
Trazodone—ABCB1—nervous system—acquired immunodeficiency syndrome	0.00016	0.00362	CbGeAlD
Trazodone—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000731	CcSEcCtD
Trazodone—Rash—Didanosine—acquired immunodeficiency syndrome	0.000154	0.000729	CcSEcCtD
Trazodone—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000729	CcSEcCtD
Trazodone—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000154	0.000729	CcSEcCtD
Trazodone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000154	0.000729	CcSEcCtD
Trazodone—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000154	0.00349	CbGeAlD
Trazodone—Headache—Didanosine—acquired immunodeficiency syndrome	0.000153	0.000725	CcSEcCtD
Trazodone—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000724	CcSEcCtD
Trazodone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000153	0.000723	CcSEcCtD
Trazodone—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000722	CcSEcCtD
Trazodone—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000722	CcSEcCtD
Trazodone—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000722	CcSEcCtD
Trazodone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000152	0.000721	CcSEcCtD
Trazodone—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000152	0.000719	CcSEcCtD
Trazodone—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000719	CcSEcCtD
Trazodone—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000718	CcSEcCtD
Trazodone—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000718	CcSEcCtD
Trazodone—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000716	CcSEcCtD
Trazodone—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000715	CcSEcCtD
Trazodone—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000151	0.000714	CcSEcCtD
Trazodone—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000151	0.000713	CcSEcCtD
Trazodone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00015	0.000712	CcSEcCtD
Trazodone—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00015	0.000711	CcSEcCtD
Trazodone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00015	0.00071	CcSEcCtD
Trazodone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00015	0.000709	CcSEcCtD
Trazodone—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000708	CcSEcCtD
Trazodone—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000708	CcSEcCtD
Trazodone—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000708	CcSEcCtD
Trazodone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000708	CcSEcCtD
Trazodone—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000149	0.000706	CcSEcCtD
Trazodone—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000706	CcSEcCtD
Trazodone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000706	CcSEcCtD
Trazodone—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000703	CcSEcCtD
Trazodone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000148	0.0007	CcSEcCtD
Trazodone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000148	0.0007	CcSEcCtD
Trazodone—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000148	0.0007	CcSEcCtD
Trazodone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000699	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000699	CcSEcCtD
Trazodone—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000147	0.000694	CcSEcCtD
Trazodone—Pain—Indinavir—acquired immunodeficiency syndrome	0.000147	0.000694	CcSEcCtD
Trazodone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.000694	CcSEcCtD
Trazodone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000147	0.000693	CcSEcCtD
Trazodone—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000692	CcSEcCtD
Trazodone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000691	CcSEcCtD
Trazodone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000146	0.00069	CcSEcCtD
Trazodone—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000146	0.00069	CcSEcCtD
Trazodone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000146	0.000689	CcSEcCtD
Trazodone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000689	CcSEcCtD
Trazodone—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000689	CcSEcCtD
Trazodone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000145	0.000687	CcSEcCtD
Trazodone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000145	0.000687	CcSEcCtD
Trazodone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000686	CcSEcCtD
Trazodone—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000686	CcSEcCtD
Trazodone—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000685	CcSEcCtD
Trazodone—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000684	CcSEcCtD
Trazodone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000684	CcSEcCtD
Trazodone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000682	CcSEcCtD
Trazodone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000681	CcSEcCtD
Trazodone—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000681	CcSEcCtD
Trazodone—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000681	CcSEcCtD
Trazodone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000679	CcSEcCtD
Trazodone—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000679	CcSEcCtD
Trazodone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000143	0.000677	CcSEcCtD
Trazodone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000673	CcSEcCtD
Trazodone—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000671	CcSEcCtD
Trazodone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000141	0.000669	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000669	CcSEcCtD
Trazodone—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000668	CcSEcCtD
Trazodone—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.000667	CcSEcCtD
Trazodone—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000666	CcSEcCtD
Trazodone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000141	0.000666	CcSEcCtD
Trazodone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00014	0.000664	CcSEcCtD
Trazodone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000664	CcSEcCtD
Trazodone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000664	CcSEcCtD
Trazodone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000662	CcSEcCtD
Trazodone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00014	0.000661	CcSEcCtD
Trazodone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.000661	CcSEcCtD
Trazodone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000659	CcSEcCtD
Trazodone—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000659	CcSEcCtD
Trazodone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000656	CcSEcCtD
Trazodone—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000656	CcSEcCtD
Trazodone—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000656	CcSEcCtD
Trazodone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000139	0.000656	CcSEcCtD
Trazodone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000139	0.000655	CcSEcCtD
Trazodone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000654	CcSEcCtD
Trazodone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000138	0.000654	CcSEcCtD
Trazodone—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000653	CcSEcCtD
Trazodone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000652	CcSEcCtD
Trazodone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000138	0.000652	CcSEcCtD
Trazodone—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.00065	CcSEcCtD
Trazodone—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.00065	CcSEcCtD
Trazodone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.00065	CcSEcCtD
Trazodone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000648	CcSEcCtD
Trazodone—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000647	CcSEcCtD
Trazodone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000136	0.000645	CcSEcCtD
Trazodone—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000643	CcSEcCtD
Trazodone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000642	CcSEcCtD
Trazodone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000136	0.000642	CcSEcCtD
Trazodone—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000136	0.000642	CcSEcCtD
Trazodone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000135	0.000641	CcSEcCtD
Trazodone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000135	0.000639	CcSEcCtD
Trazodone—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000638	CcSEcCtD
Trazodone—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000636	CcSEcCtD
Trazodone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000134	0.000635	CcSEcCtD
Trazodone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000134	0.000635	CcSEcCtD
Trazodone—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000634	CcSEcCtD
Trazodone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000134	0.000633	CcSEcCtD
Trazodone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000633	CcSEcCtD
Trazodone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000134	0.000633	CcSEcCtD
Trazodone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000632	CcSEcCtD
Trazodone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000631	CcSEcCtD
Trazodone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000133	0.000631	CcSEcCtD
Trazodone—Headache—Stavudine—acquired immunodeficiency syndrome	0.000133	0.000629	CcSEcCtD
Trazodone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000133	0.000629	CcSEcCtD
Trazodone—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000628	CcSEcCtD
Trazodone—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.000628	CcSEcCtD
Trazodone—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.000628	CcSEcCtD
Trazodone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.000627	CcSEcCtD
Trazodone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000132	0.000626	CcSEcCtD
Trazodone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000132	0.000624	CcSEcCtD
Trazodone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000132	0.000623	CcSEcCtD
Trazodone—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000623	CcSEcCtD
Trazodone—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000623	CcSEcCtD
Trazodone—Headache—Abacavir—acquired immunodeficiency syndrome	0.000131	0.00062	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000618	CcSEcCtD
Trazodone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000131	0.000618	CcSEcCtD
Trazodone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000131	0.000618	CcSEcCtD
Trazodone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000614	CcSEcCtD
Trazodone—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000613	CcSEcCtD
Trazodone—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.00061	CcSEcCtD
Trazodone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000609	CcSEcCtD
Trazodone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.000609	CcSEcCtD
Trazodone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000606	CcSEcCtD
Trazodone—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000606	CcSEcCtD
Trazodone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000605	CcSEcCtD
Trazodone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000605	CcSEcCtD
Trazodone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000603	CcSEcCtD
Trazodone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000602	CcSEcCtD
Trazodone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.0006	CcSEcCtD
Trazodone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000126	0.000598	CcSEcCtD
Trazodone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000126	0.000598	CcSEcCtD
Trazodone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000126	0.000597	CcSEcCtD
Trazodone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000126	0.000597	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000595	CcSEcCtD
Trazodone—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000594	CcSEcCtD
Trazodone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000591	CcSEcCtD
Trazodone—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.00059	CcSEcCtD
Trazodone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000124	0.000588	CcSEcCtD
Trazodone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000587	CcSEcCtD
Trazodone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000585	CcSEcCtD
Trazodone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000583	CcSEcCtD
Trazodone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000123	0.000582	CcSEcCtD
Trazodone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000582	CcSEcCtD
Trazodone—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000582	CcSEcCtD
Trazodone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000581	CcSEcCtD
Trazodone—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.00058	CcSEcCtD
Trazodone—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.00058	CcSEcCtD
Trazodone—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.00058	CcSEcCtD
Trazodone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.00058	CcSEcCtD
Trazodone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000122	0.000577	CcSEcCtD
Trazodone—ABCB1—brain—acquired immunodeficiency syndrome	0.000122	0.00277	CbGeAlD
Trazodone—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000574	CcSEcCtD
Trazodone—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000568	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000568	CcSEcCtD
Trazodone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000565	CcSEcCtD
Trazodone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000564	CcSEcCtD
Trazodone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000563	CcSEcCtD
Trazodone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.00056	CcSEcCtD
Trazodone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000559	CcSEcCtD
Trazodone—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000559	CcSEcCtD
Trazodone—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000559	CcSEcCtD
Trazodone—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000118	0.00267	CbGeAlD
Trazodone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000556	CcSEcCtD
Trazodone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000555	CcSEcCtD
Trazodone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000117	0.000555	CcSEcCtD
Trazodone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000555	CcSEcCtD
Trazodone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000554	CcSEcCtD
Trazodone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.00055	CcSEcCtD
Trazodone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.00055	CcSEcCtD
Trazodone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.00055	CcSEcCtD
Trazodone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.000547	CcSEcCtD
Trazodone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000543	CcSEcCtD
Trazodone—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000542	CcSEcCtD
Trazodone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000541	CcSEcCtD
Trazodone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000539	CcSEcCtD
Trazodone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000538	CcSEcCtD
Trazodone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000537	CcSEcCtD
Trazodone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000537	CcSEcCtD
Trazodone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000537	CcSEcCtD
Trazodone—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000537	CcSEcCtD
Trazodone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000534	CcSEcCtD
Trazodone—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000533	CcSEcCtD
Trazodone—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000533	CcSEcCtD
Trazodone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000527	CcSEcCtD
Trazodone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000525	CcSEcCtD
Trazodone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000519	CcSEcCtD
Trazodone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000519	CcSEcCtD
Trazodone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.000519	CcSEcCtD
Trazodone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000516	CcSEcCtD
Trazodone—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000516	CcSEcCtD
Trazodone—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000109	0.000516	CcSEcCtD
Trazodone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000514	CcSEcCtD
Trazodone—Rash—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000512	CcSEcCtD
Trazodone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000511	CcSEcCtD
Trazodone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.00051	CcSEcCtD
Trazodone—Headache—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000509	CcSEcCtD
Trazodone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000507	CcSEcCtD
Trazodone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000502	CcSEcCtD
Trazodone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.0005	CcSEcCtD
Trazodone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000495	CcSEcCtD
Trazodone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000493	CcSEcCtD
Trazodone—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000493	CcSEcCtD
Trazodone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000488	CcSEcCtD
Trazodone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000487	CcSEcCtD
Trazodone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000485	CcSEcCtD
Trazodone—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000484	CcSEcCtD
Trazodone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000483	CcSEcCtD
Trazodone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000482	CcSEcCtD
Trazodone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000481	CcSEcCtD
Trazodone—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000481	CcSEcCtD
Trazodone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.00048	CcSEcCtD
Trazodone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	9.91e-05	0.000469	CcSEcCtD
Trazodone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	9.86e-05	0.000467	CcSEcCtD
Trazodone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	9.82e-05	0.000464	CcSEcCtD
Trazodone—Rash—Delavirdine—acquired immunodeficiency syndrome	9.78e-05	0.000463	CcSEcCtD
Trazodone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	9.77e-05	0.000462	CcSEcCtD
Trazodone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	9.77e-05	0.000462	CcSEcCtD
Trazodone—Headache—Delavirdine—acquired immunodeficiency syndrome	9.72e-05	0.00046	CcSEcCtD
Trazodone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	9.71e-05	0.000459	CcSEcCtD
Trazodone—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.63e-05	0.000456	CcSEcCtD
Trazodone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.49e-05	0.000449	CcSEcCtD
Trazodone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.45e-05	0.000447	CcSEcCtD
Trazodone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.45e-05	0.000447	CcSEcCtD
Trazodone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	9.32e-05	0.000441	CcSEcCtD
Trazodone—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.22e-05	0.000436	CcSEcCtD
Trazodone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.13e-05	0.000432	CcSEcCtD
Trazodone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.12e-05	0.000432	CcSEcCtD
Trazodone—Rash—Ritonavir—acquired immunodeficiency syndrome	9.05e-05	0.000428	CcSEcCtD
Trazodone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.04e-05	0.000428	CcSEcCtD
Trazodone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.01e-05	0.000426	CcSEcCtD
Trazodone—Headache—Ritonavir—acquired immunodeficiency syndrome	8.99e-05	0.000425	CcSEcCtD
Trazodone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.78e-05	0.000415	CcSEcCtD
Trazodone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.71e-05	0.000412	CcSEcCtD
Trazodone—Rash—Saquinavir—acquired immunodeficiency syndrome	8.71e-05	0.000412	CcSEcCtD
Trazodone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.7e-05	0.000411	CcSEcCtD
Trazodone—Headache—Saquinavir—acquired immunodeficiency syndrome	8.65e-05	0.000409	CcSEcCtD
Trazodone—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.52e-05	0.000403	CcSEcCtD
Trazodone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.38e-05	0.000396	CcSEcCtD
Trazodone—Rash—Lamivudine—acquired immunodeficiency syndrome	8.31e-05	0.000393	CcSEcCtD
Trazodone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.3e-05	0.000393	CcSEcCtD
Trazodone—Headache—Lamivudine—acquired immunodeficiency syndrome	8.25e-05	0.00039	CcSEcCtD
Trazodone—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.2e-05	0.000388	CcSEcCtD
Trazodone—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.82e-05	0.00037	CcSEcCtD
Trazodone—SLC6A4—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	9.61e-06	0.00193	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	9.58e-06	0.00192	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	9.56e-06	0.00192	CbGpPWpGaD
Trazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	9.56e-06	0.00192	CbGpPWpGaD
Trazodone—HTR1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	9.55e-06	0.00192	CbGpPWpGaD
Trazodone—HTR2C—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	9.5e-06	0.00191	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	9.4e-06	0.00189	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	9.38e-06	0.00188	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	9.34e-06	0.00188	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	9.31e-06	0.00187	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	9.18e-06	0.00184	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	8.94e-06	0.00179	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	8.94e-06	0.00179	CbGpPWpGaD
Trazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	8.88e-06	0.00178	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	8.75e-06	0.00176	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	8.75e-06	0.00176	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	8.72e-06	0.00175	CbGpPWpGaD
Trazodone—HTR1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	8.61e-06	0.00173	CbGpPWpGaD
Trazodone—HTR2C—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	8.56e-06	0.00172	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AGPS—acquired immunodeficiency syndrome	8.52e-06	0.00171	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	8.45e-06	0.0017	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—IFNA1—acquired immunodeficiency syndrome	8.45e-06	0.0017	CbGpPWpGaD
Trazodone—ADRA2A—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	8.36e-06	0.00168	CbGpPWpGaD
Trazodone—HTR1A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	8.3e-06	0.00167	CbGpPWpGaD
Trazodone—HTR2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	8.25e-06	0.00166	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	8.23e-06	0.00165	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	8.08e-06	0.00162	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	8.08e-06	0.00162	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	7.95e-06	0.0016	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	7.95e-06	0.0016	CbGpPWpGaD
Trazodone—SLC6A4—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	7.85e-06	0.00158	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	7.81e-06	0.00157	CbGpPWpGaD
Trazodone—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	7.78e-06	0.00156	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.58e-06	0.00152	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	7.55e-06	0.00152	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.54e-06	0.00151	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	7.51e-06	0.00151	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	7.51e-06	0.00151	CbGpPWpGaD
Trazodone—HTR2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	7.43e-06	0.00149	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	7.42e-06	0.00149	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	7.28e-06	0.00146	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	7.25e-06	0.00146	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	7.25e-06	0.00146	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	7.21e-06	0.00145	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	7.21e-06	0.00145	CbGpPWpGaD
Trazodone—HTR2A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	7.17e-06	0.00144	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	7.1e-06	0.00142	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	7.1e-06	0.00142	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	7.06e-06	0.00142	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	7.06e-06	0.00142	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	6.93e-06	0.00139	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	6.85e-06	0.00138	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	6.82e-06	0.00137	CbGpPWpGaD
Trazodone—ADRA2A—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	6.78e-06	0.00136	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	6.76e-06	0.00136	CbGpPWpGaD
Trazodone—HTR1A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	6.7e-06	0.00135	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	6.66e-06	0.00134	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—CSF2—acquired immunodeficiency syndrome	6.61e-06	0.00133	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	6.56e-06	0.00132	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.55e-06	0.00132	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	6.55e-06	0.00131	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	6.53e-06	0.00131	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	6.53e-06	0.00131	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	6.52e-06	0.00131	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.52e-06	0.00131	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	6.51e-06	0.00131	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	6.44e-06	0.00129	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	6.44e-06	0.00129	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	6.41e-06	0.00129	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	6.41e-06	0.00129	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	6.41e-06	0.00129	CbGpPWpGaD
Trazodone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	6.39e-06	0.00128	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	6.38e-06	0.00128	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	6.26e-06	0.00126	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	6.26e-06	0.00126	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	6.25e-06	0.00125	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	6.25e-06	0.00125	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	6.13e-06	0.00123	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	6.13e-06	0.00123	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	6.13e-06	0.00123	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	6.13e-06	0.00123	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	6.12e-06	0.00123	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	6.12e-06	0.00123	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	6.04e-06	0.00121	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	6e-06	0.00121	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	6e-06	0.00121	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	6e-06	0.0012	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.96e-06	0.0012	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	5.95e-06	0.0012	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.93e-06	0.00119	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.92e-06	0.00119	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.91e-06	0.00119	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	5.89e-06	0.00118	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.8e-06	0.00116	CbGpPWpGaD
Trazodone—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	5.79e-06	0.00116	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.69e-06	0.00114	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.69e-06	0.00114	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.66e-06	0.00114	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.65e-06	0.00113	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	5.58e-06	0.00112	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	5.58e-06	0.00112	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.57e-06	0.00112	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.57e-06	0.00112	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.55e-06	0.00112	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.55e-06	0.00112	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	5.55e-06	0.00111	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.54e-06	0.00111	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.52e-06	0.00111	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.45e-06	0.00109	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.45e-06	0.00109	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	5.45e-06	0.00109	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.4e-06	0.00108	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.39e-06	0.00108	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.37e-06	0.00108	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.32e-06	0.00107	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.29e-06	0.00106	CbGpPWpGaD
Trazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	5.16e-06	0.00104	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.15e-06	0.00103	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.06e-06	0.00102	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.06e-06	0.00102	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.99e-06	0.001	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.9e-06	0.000984	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.88e-06	0.000979	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.86e-06	0.000977	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.84e-06	0.000972	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.83e-06	0.00097	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.8e-06	0.000965	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.69e-06	0.000943	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.69e-06	0.000943	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.66e-06	0.000936	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.65e-06	0.000934	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.59e-06	0.000922	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.58e-06	0.00092	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.57e-06	0.000917	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.5e-06	0.000903	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	4.48e-06	0.000899	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.48e-06	0.000899	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	4.47e-06	0.000897	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.45e-06	0.000894	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.42e-06	0.000887	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.39e-06	0.000882	CbGpPWpGaD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	4.38e-06	0.00088	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	4.31e-06	0.000865	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	4.27e-06	0.000857	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.24e-06	0.000852	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.23e-06	0.00085	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.23e-06	0.000849	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.2e-06	0.000844	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.19e-06	0.000842	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.18e-06	0.000839	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.17e-06	0.000838	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.16e-06	0.000836	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.15e-06	0.000833	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.11e-06	0.000826	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.08e-06	0.00082	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.05e-06	0.000813	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.03e-06	0.000809	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.87e-06	0.000777	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.86e-06	0.000775	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.85e-06	0.000774	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	3.84e-06	0.000771	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.82e-06	0.000768	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.82e-06	0.000766	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.81e-06	0.000765	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.81e-06	0.000764	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.81e-06	0.000764	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.79e-06	0.000762	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.79e-06	0.00076	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.79e-06	0.00076	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.79e-06	0.00076	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.74e-06	0.00075	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	3.63e-06	0.000729	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.57e-06	0.000717	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.52e-06	0.000707	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.52e-06	0.000706	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.5e-06	0.000702	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	3.49e-06	0.000702	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.49e-06	0.000701	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.47e-06	0.000697	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.46e-06	0.000696	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.42e-06	0.000688	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.29e-06	0.00066	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.29e-06	0.00066	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.28e-06	0.000659	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.28e-06	0.000659	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.22e-06	0.000647	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.22e-06	0.000647	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.22e-06	0.000646	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.18e-06	0.000639	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.15e-06	0.000632	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.99e-06	0.000601	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.99e-06	0.000601	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.9e-06	0.000582	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.88e-06	0.000579	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.85e-06	0.000573	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.84e-06	0.00057	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.81e-06	0.000564	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.8e-06	0.000561	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.61e-06	0.000524	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.6e-06	0.000521	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.58e-06	0.000518	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.55e-06	0.000512	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.54e-06	0.00051	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.5e-06	0.000502	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.5e-06	0.000501	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.46e-06	0.000495	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.46e-06	0.000494	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.45e-06	0.000492	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.43e-06	0.000487	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.42e-06	0.000486	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.41e-06	0.000485	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.38e-06	0.000477	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.28e-06	0.000457	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.25e-06	0.000453	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.25e-06	0.000452	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.24e-06	0.00045	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	2.21e-06	0.000445	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.21e-06	0.000443	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.21e-06	0.000443	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.2e-06	0.000443	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.2e-06	0.000442	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.16e-06	0.000433	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.05e-06	0.000412	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.01e-06	0.000403	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.86e-06	0.000373	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.85e-06	0.000371	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	1.75e-06	0.000351	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-06	0.000322	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.51e-06	0.000303	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.5e-06	0.000301	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.5e-06	0.000301	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.49e-06	0.0003	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.3e-06	0.000262	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.3e-06	0.000261	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.3e-06	0.00026	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.29e-06	0.00026	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.28e-06	0.000256	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.27e-06	0.000255	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	1.21e-06	0.000243	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.18e-06	0.000238	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.18e-06	0.000237	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	1.14e-06	0.000229	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.09e-06	0.000219	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.86e-07	0.000178	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.81e-07	0.000177	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.65e-07	0.000154	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.64e-07	0.000153	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.49e-07	0.000151	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	7.44e-07	0.000149	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.96e-07	0.00014	CbGpPWpGaD
